Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

BOLT

Bolt Biotherapeutics, Inc.

CIK 0001641281 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$3.67
↑ 0.46 (14.53%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$7.04M
P/E Ratio
-0.25
EPS
-17.85
Dividend Yield
Not covered
52W Position
13%
Beta
0.72

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.56
P/S
1.50
EV/Revenue
-1.24
ROE
-227.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$3.13$7.20

Latest Financials

2025-12-31 FY
Revenue
$7.70M
Net Income
-$33.38M
Total Assets
$56.75M
Free Cash Flow
-$39.92M

Recent news